BSX vs CAH
BSX: A global medical-device innovator developing minimally invasive solutions for cardiovascular, rhythm management, and endoscopic procedures. CAH: Cardinal Health is a healthcare services and logistics company that distributes pharmaceuticals, medical supplies, and healthcare IT solutions to pharmacies, hospitals, and health systems globally.
Side-by-side fundamentals
| Metric | BSX | CAH | Edge |
|---|---|---|---|
| Price as of 2026-07-09 close | $44.99 | $233.77 | |
| Market cap as of 2026-07-10 | $66.9B | $55.3B | |
| P/E as of 2026-07-10 | 18.77 | 35.56 | BSX lower |
| PEG as of 2026-07-10 | 0.25 | 2.07 | BSX lower |
| Net margin as of 2026-07-10 | +17.3% | +0.6% | BSX higher |
| Gross margin as of 2026-07-10 | +69.1% | +3.8% | BSX higher |
| Operating margin as of 2026-07-10 | +18.4% | +0.9% | BSX higher |
| ROE as of 2026-07-10 | +14.9% | +37.2% | CAH higher |
| ROA as of 2026-07-10 | +8.3% | +2.8% | BSX higher |
| Debt / equity as of 2026-07-10 | 0.43 | 5.65 | BSX lower |
| Revenue growth (YoY) as of 2026-07-10 | +17.4% | +12.9% | BSX higher |
| Revenue CAGR (3y) SEC XBRL | +16.5% | +7.1% | BSX higher |
| Dividend yield as of 2026-07-10 | +0.0% | +0.9% | CAH higher |
| Dividend streak (yrs) SEC XBRL | n/a | 5 | |
| Beta as of 2026-07-10 | 0.58 | 0.52 | |
| 1-year return as of 2026-07-09 close | -56.2% | +42.3% | CAH higher |
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.